Multicenter randomized phase II trial of S-1/ L-OHP (SOX) as an adjuvant treatment after resection of liver metastasis from colorectal carcinoma
Phase 2
Recruiting
- Conditions
- Cases with liver metastasis from colorectal carcinoma, which is removed curatively and surgically
- Registration Number
- JPRN-UMIN000004029
- Lead Sponsor
- Yokohama City University Graduate School of Medicine Gastroenterological surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
The patients with other malignant disease, post-operative severe complications, and surgical margin positivity.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Discontinuation rate associated with toxicity
- Secondary Outcome Measures
Name Time Method Relapse-free survival Disease-free survival Toxicity